OUR VISION is to be the world’s leader in nanosensor-based, point-of-care diagnostics for a wide variety of diseases including Covid-19, Traumatic Brain Injury (TBI), Sepsis and Stroke.
OUR VALUES include holding ourselves to the highest quality standards, driving to be the best in the industry, both individually and collectively, and having the highest levels of integrity and ethical behavior.
1945 – 2021
In memory of our dear friend and colleague Bob Mercier. Bob was instrumental in the initial launch of BioDirection® (now NanoDx™) over 11 years ago and joined our Board of Directors when it was formed in 2012. Bob was a committed, hardworking member of the NanoDx team. His unique capability of considering diverse opinions to arrive at optimal outcomes was an invaluable asset to our Board and company. Bob was a terriﬁc guy who loved ﬁshing, card games, and spending time with his family. Bob will be forever missed by us all.
James A. Wylie
President & CEO
Board Member, Chairman of Sports Advisory Board
Ph.D., M.Sc., EMBA
Founder, Executive Vice President, Chief Technical Officer
NanoDx™ is always searching for new opportunities. Contact us today with any questions or inquiries.